anmelden
Analysen von Andrew Baum
| 27.05.15 | AstraZeneca buy | Citigroup Corp. | |
| 21.05.15 | AstraZeneca buy | Citigroup Corp. | |
| 21.05.15 | Novartis buy | Citigroup Corp. | |
| 21.05.15 | GSK neutral | Citigroup Corp. | |
| 12.05.15 | Novartis buy | Citigroup Corp. | |
| 29.04.15 | Bayer buy | Citigroup Corp. | |
| 29.04.15 | Novartis buy | Citigroup Corp. | |
| 29.04.15 | Roche Neutral | Citigroup Corp. | |
|
Werbung
|
|||
| 29.04.15 | Sanofi Neutral | Citigroup Corp. | |
| 29.04.15 | AstraZeneca buy | Citigroup Corp. | |
| 07.04.15 | Roche Neutral | Citigroup Corp. | |
| 09.02.15 | Novartis buy | Citigroup Corp. | |
| 09.02.15 | Roche Neutral | Citigroup Corp. | |
| 19.11.14 | AstraZeneca buy | Citigroup Corp. | |
| 31.10.14 | AstraZeneca buy | Citigroup Corp. | |
| 22.10.14 | Roche buy | Citigroup Corp. | |
| 14.10.14 | Roche buy | Citigroup Corp. | |
| 29.07.14 | Roche buy | Citigroup Corp. | |
| 29.07.14 | AstraZeneca buy | Citigroup Corp. | |
| 08.07.14 | Merck Neutral | Citigroup Corp. | |
| 28.05.14 | Merck Neutral | Citigroup Corp. | |
| 28.05.14 | Bayer buy | Citigroup Corp. | |
| 20.05.14 | AstraZeneca buy | Citigroup Corp. | |
| 19.05.14 | AstraZeneca buy | Citigroup Corp. | |
| 25.04.14 | AstraZeneca buy | Citigroup Corp. | |
| 22.04.14 | AstraZeneca buy | Citigroup Corp. | |
| 25.01.11 | AstraZeneca overweight | Morgan Stanley | |
| 25.01.11 | Novartis overweight | Morgan Stanley | |
| 15.12.10 | AstraZeneca overweight | Morgan Stanley | |
| 01.12.10 | Novartis overweight | Morgan Stanley | |
| 12.11.10 | Novartis overweight | Morgan Stanley | |
| 19.10.10 | Novo Nordisk overweight | Morgan Stanley | |
| 23.09.10 | Novartis overweight | Morgan Stanley | |
| 15.09.10 | Novo Nordisk overweight | Morgan Stanley | |
| 02.09.10 | AstraZeneca overweight | Morgan Stanley | |
| 31.08.10 | Sanofi equal-weight | Morgan Stanley | |
| 17.08.10 | EGIS Pharmaceuticals overweight | Morgan Stanley | |
| 15.07.10 | GSK halten | Morgan Stanley | |
| 07.07.10 | Novartis kaufen | Morgan Stanley | |
| 30.06.10 | AstraZeneca kaufen | Morgan Stanley | |
